company-logo

Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. It has strategic collaborations with Recipharm, Merck & Cie, and Sahlgrenska University Hospital. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden.

Isofol Medical Dividend Announcement

Isofol Medical does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Isofol Medical dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Isofol Medical Dividend History

Isofol Medical Dividend Yield

Isofol Medical current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Isofol Medical stock? Use our calculator to estimate your expected dividend yield:

Isofol Medical Financial Ratios

P/E ratio-10.36
PEG ratio-1.88
P/B ratio4.47
ROE-36.76%
Payout ratio0.00%
Current ratio5.98
Quick ratio5.98
Cash Ratio5.65

Isofol Medical Dividend FAQ

Does Isofol Medical stock pay dividends?
Isofol Medical does not currently pay dividends to its shareholders.
Has Isofol Medical ever paid a dividend?
No, Isofol Medical has no a history of paying dividends to its shareholders. Isofol Medical is not known for its dividend payments.
Why doesn't Isofol Medical pay dividends?
There are several potential reasons why Isofol Medical would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Isofol Medical ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Isofol Medical has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Isofol Medical a dividend aristocrat?
Isofol Medical is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Isofol Medical a dividend king?
Isofol Medical is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Isofol Medical a dividend stock?
No, Isofol Medical is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Isofol Medical stocks?
To buy Isofol Medical you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Isofol Medical stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.